Movers From Yesterday

Gainers Nutex Health Inc. (NASDAQ: NUTX) jumped 72.4% to settle at $0.9551 on Thursday. Nutex Health recently provided a corporate update. FedNat Holding Company (NASDAQ: FNHC) shares surged 56.5% to close at $0.3513 on Thursday after dipping 34% on Wednesday. Digital Brands Group, Inc. (NASDAQ:...

Gainers Pintec Technology Holdings Limited (NASDAQ: PT) shares jumped 216.2% to close at $0.9058 on Wednesday. Agrify Corporation (NASDAQ: AGFY) climbed 88% to close at $ 0.9540 on Wednesday after climbing over 32% on Tuesday. FLJ Group Limited (NASDAQ: FLJ) jumped 86.3% to close at $2.85 on...

Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday. DICE Therapeutics, Inc. (NASDAQ: DICE) shares gained 62.3% to close at $40.00 after the company announced topline data from its Phase 1 clinical trial of DC-806. Clinical proof-of-concept in...

Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued above the mid-six-figures. Immunic, Inc. (NASDAQ: IMUX) jumped 56.6% to close at $6.20 after...

Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday. Inventiva S.A. (NASDAQ: IVA) climbed 69.5% to settle at $7.05 after gaining around 10% on Thursday. Minim, Inc. (NASDAQ:...

Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday. Atlis Motor Vehicles, Inc. (NASDAQ: AMV) climbed 95.5% to close at $24.49. InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) gained 83% to settle at $7.98. Pineapple Energy Inc. (NASDAQ: PEGY)...

Gainers Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday. Nauticus Robotics, Inc. (NASDAQ: KITT) shares jumped 96.3% to close at $6.32 on Wednesday after the company said it was awarded a second multi-million dollar contract by the U.S....

    Losers   KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) shares dipped 58.9% to close at $5.85 on Tuesday after the company announced it terminated the KOMPLETE phase 2 clinical trial for KVD824 for the prevention of attacks in people with hereditary angioedema. Oblong, Inc (...

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share. FedNat Holding Company (NASDAQ: FNHC) jumped 308.7% to close at $0.47 after dipping...

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target. BigBear.ai Holdings, Inc. (NYSE: BBAI) climbed 30.3% to close at $1.55 after the company announced it was...

Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint. Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) shares rose 103.8% to...

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares climbed 106.3% to close at $9.15. Avenue Therapeutics recently received the official meeting minutes from the FDA regarding a meeting conducted for IV Tramadol in combination with other opioid analgesics to manage moderate-to-moderately...

Gainers LAVA Therapeutics N.V. (NASDAQ: LVTX) shares climbed 97.5% to close at $4.74 on Monday after the company and Seagen Inc (NASDAQ: SGEN) announced an exclusive license agreement in which Seagen will work to develop, manufacture and commercialize LAVA-1223. DIRTT Environmental Solutions Ltd...

Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday. Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares climbed 46.4% to close at $0.3750 on Friday. Kiromic BioPharma, said on Sept. 15, that the company received letter from the Nasdaq that co. has...

Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) shares jumped 167.7% to close at $2.20 on Thursday after the company announced it has entered into an exclusive license agreement with GSK for Spero's late-stage antibiotic asset, tebipenem HBr. Spero Therapeutics will receive $66 million upfront...